FDAnews Device Daily Bulletin
Sept. 13, 2012 | Vol. 9 No. 180
Mobile medical apps that run on such consumer devices as smartphones and tablets represent a rapidly growing and lucrative device market for innovative companies that do their homework before diving in, an expert in the field says.
Brazil’s Anvisa should be operating again at full capacity by mid-September, following government strikes that crippled the agency this summer and left devicemakers unable to obtain registration licenses or get their products in and out of the country.
With Welch-Allyn’s announcement this week it will cut 10 percent of its workforce, the company joins a group of medical device manufacturers saying they’ll be hurt by a new tax that starts in January.
South Florida law firm Searcy Denney Scarola Barnhart & Shipley announced it has filed seven additional lawsuits against Stryker Orthopaedics, over the company’s Rejuvenate and ABG II hip implant systems.
CardioComm Solutions submitted an application with the FDA for clearance of its GUAVATM II ECG viewer technology.
As most of us are reminded every time we shop for a new phone, it’s hard to keep up with technology.
Long regarded as the “Wild, Wild West” of the healthcare landscape, mobile healthcare is slowly coming to grips with its need for protection and cooperation.
General Dynamics’ Information Technology unit has won a $41.8 million task order to support the U.S. Army Medical Materiel Development Activity’s efforts to develop advanced medical products.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.